Form 4 for RMD ResMed|
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001127602-23-018089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-07 | 2023-06-05 | RMD | PENDARVIS DAVID | Chief Administrative Off | S - Sale | $219.79 | -1,500 | 89.7K | -2% | -$329.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-06-05 | S | D | 1,500 | $219.79 | 89,729 | D | — | — | (F2) Includes 56.7807 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan. |